KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer

Haijie Li; Xi Yang; Guihua Wang; Xiaolan Li; Deding Tao; Junbo Hu; Xuelai Luo

doi:10.18632/oncotarget.11077

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer

Haijie Li, Xi Yang, Guihua Wang, Xiaolan Li, Deding Tao, Junbo Hu and Xuelai Luo _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:57866-57877. https://doi.org/10.18632/oncotarget.11077

Metrics: PDF 3353 views | HTML 3122 views | ?

Abstract

Haijie Li1,*, Xi Yang1,*, Guihua Wang1, Xiaolan Li1, Deding Tao1, Junbo Hu1, Xuelai Luo1

1Cancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China

*These authors contributed equally to this work

Correspondence to:

Xuelai Luo, email: [email protected]

Keywords: KDM4B, HAX1, mitochondrial apoptosis, colorectal cancer

Received: November 15, 2015 Accepted: July 17, 2016 Published: August 05, 2016

ABSTRACT

Histone methyltransferases and demethylases regulate transcription by altering the epigenetic marks on histones in tumorigenesis. Members of the histone lysine(K)-specific demethylase 4 (KDM4) family are dysregulated in several types of cancer. Here, we report a novel role for KDM4B in mitochondrial apoptosis. In this study, we demonstrate that KDM4B is overexpressed in colorectal cancer (CRC) tissues. Decreased expression of KDM4B significantly promoted apoptosis of CRC cell lines. Moreover, our data indicate that HAX1 is required for KDM4B-mediated mitochondrial apoptosis. The transcription of HAX1 was directly activated by KDM4B. We also show that HAX1 is overexpressed in CRC tissues and is positively correlated with KMD4B expression. Collectively, we demonstrate that KDM4B may play an important role in mitochondrial apoptosis and represent a potential therapeutic cancer target in CRC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11077

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer

Abstract